Maryland Medical Assistance Program, Maryland Children's Health Program, and Health Insurance - Transfers to Special Pediatric Hospitals - Requirements
HB1376 requires the Maryland Department of Health to expand an existing 2024 contract with an independent consultant so the consultant also studies the current provision of health care services in Maryland. In addition to reviewing the structure and functions of the Health Services Cost Review Commission, the Maryland Health Care Commission, the Maryland Community Health Resources Commission, and the Maryland Insurance Administration, the study must now examine the State’s overall health care delivery system, including programs and payors, and recommend ways to consolidate or better align them to maximize coverage for residents.
The bill also directs the consultant to produce a broader report on Maryland’s health care finance and delivery system. That report must synthesize existing analyses of cost, quality, workforce, and provider consolidation trends; review strategies used in other states to expand coverage and improve affordability; and recommend strategies and possible funding options to ensure timely access to high-quality, affordable health care for all Marylanders. The Department must report the results to the Governor and legislative committees by January 1, 2026, and the act takes effect June 1, 2025.
The bill amends Chapters 794 and 795 of the Acts of 2024 by adding new study requirements to the Maryland Department of Health’s consultant contract. It does not directly change benefit eligibility, reimbursement rules, or agency powers, but it expands the scope of the mandated policy review to include statewide health care program and payer consolidation, system performance, and potential financing strategies. The practical effect is to create a legislative foundation for future reforms affecting Medicaid, the Maryland Children’s Health Program, private coverage, and the broader health care regulatory structure.
The available record shows no committee transcript or recorded vote debate, so there is no detailed public discussion to gauge. Based on the bill’s text and its advancement to passage, the measure appears to have been treated as a policy study bill with a generally constructive, reform-oriented purpose. Its framing around coverage, affordability, and system efficiency suggests broad interest in evaluating Maryland’s health care structure rather than immediate partisan conflict.
The main substantive issue is the bill’s call to study consolidation of payors and programs, which could raise concerns among agencies, providers, insurers, and advocates who may worry about centralization, administrative disruption, or changes to existing roles. Another possible point of tension is the bill’s broad mandate to assess statewide health care coverage and funding options, which could imply future reforms affecting Medicaid, public programs, and private insurance markets. However, no specific objections or supporters are documented in the provided materials.